Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Cardiovascular disease

Should statin therapy be expanded in patients with CKD?

Nature Reviews Nephrology volume 8, pages 440–441 (2012)Cite this article

Subjects

The use of statins as a line of primary prevention in individuals at low risk of cardiovascular events is an area of debate. The most recent meta-analysis from the Cholesterol Treatment Trialists' (CTT) Collaboration suggests that present guidelines for prescribing statin therapy may need to be reconsidered.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Cholesterol Treatment Trialists' Collaboration. Protocol for a prospective collaborative overview of all current and planned randomized trials of cholesterol treatment regimens. Cholesterol Treatment Trialists' (CTT) Collaboration. Am. J. Cardiol. 75, 1130–1134 (1995).

  2. Cholesterol Treatment Trialists' Collaboration. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet http://dx.doi.org/10.1016/S0140-6736(12)60367-5.

  3. Taylor, F. et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews, Issue 1. Art. No.: CD004816 (2011). http://dx.doi.org/10.1002/14651858.CD004816.pub4.

  4. Ray, K. K. et al. Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants. Arch. Intern. Med. 170, 1024–1031 (2010).

    Article  CAS  Google Scholar 

  5. Tonelli, M. et al. Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis. CMAJ 183, E1189–E1202 (2011).

    Article  Google Scholar 

  6. Baigent, C. et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet 377, 2181–2192 (2011).

    Article  CAS  Google Scholar 

  7. Wanner, C. et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N. Engl. J. Med. 353, 238–248 (2005).

    Article  CAS  Google Scholar 

  8. Fellstrom, B. C. et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N. Engl. J. Med. 360, 1395–1407 (2009).

    Article  CAS  Google Scholar 

  9. Navaneethan, S. D., Hegbrant, J. & Strippoli, G. F. Role of statins in preventing adverse cardiovascular outcomes in patients with chronic kidney disease. Curr. Opin. Nephrol. Hypertens. 20, 146–152 (2011).

    Article  CAS  Google Scholar 

  10. Ridker, P. M. et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N. Engl. J. Med. 359, 2195–2207 (2008).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Renal Diseases and Hypertension, University of Colorado Denver Anschutz Medical Center, 12700 East 19th Avenue C281, Aurora, 80045, CO, USA

    Kristen L. Jablonski & Michel Chonchol

Authors
  1. Kristen L. Jablonski
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michel Chonchol
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kristen L. Jablonski.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jablonski, K., Chonchol, M. Should statin therapy be expanded in patients with CKD?. Nat Rev Nephrol 8, 440–441 (2012). https://doi.org/10.1038/nrneph.2012.142

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneph.2012.142

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing